Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs

Shaohang Cai(Key Laboratory of Guangdong Province), Jie Peng(Guiyang Medical University), Muye Xia(Southern Medical University), Tao Yu(Nanfang Hospital), Zhandong Li(Southern Medical University)
Infection and Drug Resistance
April 1, 2018
10.2147/idr.s163038
Cited by 43

Related Papers

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging
|European Radiology|2019|219
Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling
|Cancer Research|2021|127
ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China
|medRxiv|2020|112
<i>Retracted:</i><scp>HB</scp>x‐mediated decrease of <scp>AIM</scp>2 contributes to hepatocellular carcinoma metastasis
|Molecular Oncology|2017|92
Association Between Clinical Manifestations and Prognosis in Patients with COVID-19
|Clinical Therapeutics|2020|84